JP6591398B2 - インフルエンザ診断のための方法及びキット - Google Patents

インフルエンザ診断のための方法及びキット Download PDF

Info

Publication number
JP6591398B2
JP6591398B2 JP2016506385A JP2016506385A JP6591398B2 JP 6591398 B2 JP6591398 B2 JP 6591398B2 JP 2016506385 A JP2016506385 A JP 2016506385A JP 2016506385 A JP2016506385 A JP 2016506385A JP 6591398 B2 JP6591398 B2 JP 6591398B2
Authority
JP
Japan
Prior art keywords
neuraminidase
influenza
sample
test
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016506385A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016524127A5 (enExample
JP2016524127A (ja
Inventor
ロバート・キャンベル
ケヴィン・ジー・ドラン
エリック・ファローズ
ランダル・エー・ホーク
ロス・ジェイコブソン
ジェイ・ブルース・ピットナー
グレン・ヴォンク
ラジャシャカール・カッチェ
ウプマ・グラティ
ヘルマン・ヒメル
ローズマリー・ビー・エヴァンス−ストームス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson and Co
Original Assignee
Becton Dickinson and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson and Co filed Critical Becton Dickinson and Co
Publication of JP2016524127A publication Critical patent/JP2016524127A/ja
Publication of JP2016524127A5 publication Critical patent/JP2016524127A5/ja
Application granted granted Critical
Publication of JP6591398B2 publication Critical patent/JP6591398B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/11—Orthomyxoviridae, e.g. influenza virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Saccharide Compounds (AREA)
JP2016506385A 2013-04-01 2014-04-01 インフルエンザ診断のための方法及びキット Active JP6591398B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361807185P 2013-04-01 2013-04-01
US61/807,185 2013-04-01
PCT/US2014/032567 WO2014165536A1 (en) 2013-04-01 2014-04-01 Methods and kits for the diagnosis of influenza

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019169472A Division JP7096219B2 (ja) 2013-04-01 2019-09-18 インフルエンザ診断のための方法及びキット

Publications (3)

Publication Number Publication Date
JP2016524127A JP2016524127A (ja) 2016-08-12
JP2016524127A5 JP2016524127A5 (enExample) 2017-05-18
JP6591398B2 true JP6591398B2 (ja) 2019-10-16

Family

ID=50625220

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016506385A Active JP6591398B2 (ja) 2013-04-01 2014-04-01 インフルエンザ診断のための方法及びキット
JP2019169472A Active JP7096219B2 (ja) 2013-04-01 2019-09-18 インフルエンザ診断のための方法及びキット

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019169472A Active JP7096219B2 (ja) 2013-04-01 2019-09-18 インフルエンザ診断のための方法及びキット

Country Status (11)

Country Link
US (3) US10317404B2 (enExample)
EP (1) EP2981618B1 (enExample)
JP (2) JP6591398B2 (enExample)
KR (1) KR102348484B1 (enExample)
CN (2) CN105264086B (enExample)
AU (2) AU2014248225B2 (enExample)
BR (1) BR112015025042B1 (enExample)
CA (1) CA2908028C (enExample)
ES (1) ES2754402T3 (enExample)
RU (1) RU2713112C2 (enExample)
WO (1) WO2014165536A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6411740B2 (ja) * 2013-01-15 2018-10-24 国立大学法人広島大学 ノイラミニダーゼ活性阻害剤の有効性を判定するための組成物、キットおよびその利用
AU2014248225B2 (en) 2013-04-01 2020-06-25 Becton, Dickinson And Company Methods and kits for the diagnosis of influenza
US10520498B2 (en) 2017-03-14 2019-12-31 Becton, Dickinson And Company Devices and techniques for oral fluid collection and seroprotection testing
WO2019009793A1 (en) * 2017-07-04 2019-01-10 Cavidi Ab METHOD FOR ASSESSING THE SENSITIVITY OF A VIRUS TO TREATMENT BY MEASURING ENZYMA ACTIVITY AND SYSTEM THEREOF
JP7303799B2 (ja) 2017-09-21 2023-07-05 ベクトン・ディキンソン・アンド・カンパニー 有害汚染物質検査のための反応性分画テンプレート
AU2018337027B2 (en) 2017-09-21 2024-06-06 Becton, Dickinson And Company Hazardous contaminant collection kit and rapid testing
CN111107939B (zh) 2017-09-21 2022-04-12 贝克顿·迪金森公司 引导有害污染物样品的收集的系统和模板及使用其的方法
JP7223749B2 (ja) * 2017-09-21 2023-02-16 ベクトン・ディキンソン・アンド・カンパニー 危険汚染物質の試験における高ダイナミックレンジの分析器
EP3684944B1 (en) 2017-09-21 2025-01-01 Becton, Dickinson and Company Hazardous contaminant collection kit and rapid testing
CN111278987B (zh) * 2017-09-21 2024-02-23 贝克顿·迪金森公司 以高拾取和脱落效率收集有害污染物的采样系统和技术
ES3037747T3 (en) 2017-09-21 2025-10-06 Becton Dickinson Co Augmented reality devices for hazardous contaminant testing
JP7225201B2 (ja) * 2018-03-02 2023-02-20 日本農薬株式会社 アミド化合物又はその塩類、及びそれらの化合物を含有する農園芸用殺菌剤並びにその使用方法
KR102129937B1 (ko) 2018-07-31 2020-07-03 재단법인 아산사회복지재단 종이기반 핵산검출용 키트 및 pcr 증폭산물을 분석하기 위한 방법
MY204234A (en) 2018-08-27 2024-08-16 Regeneron Pharma Use of raman spectroscopy in downstream purification
CN113383222A (zh) 2019-01-28 2021-09-10 贝克顿·迪金森公司 具有集成的拭子和测试装置的有害污染物收集装置
CN113614534A (zh) * 2019-03-25 2021-11-05 积水医疗株式会社 呼吸道病毒的免疫测定方法和检测试剂盒
CA3183061A1 (en) * 2020-06-15 2021-12-23 Neuome Peptides Pte. Ltd. Lateral flow assay device for detection of analytes and method of detection thereof
JP2022018768A (ja) * 2020-07-16 2022-01-27 デンカ株式会社 簡易鼻腔粘膜表面付着粘液の採取方法および該検体中の被検出物を検出するための検査キット
KR20220060269A (ko) 2020-11-04 2022-05-11 인텔로스 주식회사 코로나 바이러스 감염증 및 인플루엔자 바이러스 감염증 동시 진단키트
KR102265441B1 (ko) * 2020-12-23 2021-06-15 충남대학교 산학협력단 화학 발광 기반의 조류 인플루엔자 바이러스 검출용 조성물 및 이의 용도
CN115015541A (zh) 2021-03-05 2022-09-06 全球诊断系统受益有限责任公司 带流体贮存器的诊断装置及相关方法和试剂盒
JP2023016529A (ja) * 2021-07-21 2023-02-02 東洋紡株式会社 イムノクロマト試験片
JP2023016530A (ja) * 2021-07-21 2023-02-02 東洋紡株式会社 イムノクロマト試験片
US20250066867A1 (en) * 2023-08-23 2025-02-27 Vedabio, Inc. Rapid detection of known and emerging influenza viruses

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4590169A (en) 1983-11-18 1986-05-20 Beckman Instruments, Inc. Direct particle agglutination immunoassays avoiding false negatives at high antigen concentrations
US4810631A (en) 1986-05-12 1989-03-07 Becton, Dickinson And Company Signal enhancement in immunoassay by modulation of chemical catalysis
US4835099A (en) 1986-11-20 1989-05-30 Becton, Dickinson And Company Signal enhancement in immunoassay by modulation of enzymatic catalysis
US4904583A (en) 1987-05-26 1990-02-27 Becton, Dickinson And Company Cascade immunoassay by multiple binding reactions
US5017473A (en) 1987-05-26 1991-05-21 Becton, Dickinson And Company Homogeneous chemiluminescence immunoassay using a light absorbing material
CA2000678A1 (en) * 1988-11-17 1990-05-17 John E. Reardon Chromogenic substrate for esterase and immunoassay using same
DK0507854T3 (da) 1989-12-29 1997-05-12 Oklahoma Med Res Found Fremgangsmåder til diagnosticering af human-influenza og chromogene N-acetylneuraminsyresubstrater, der er modificerede i 4-positionen, til anvendelse deri
US5314801A (en) 1992-11-06 1994-05-24 Becton, Dickinson And Company Probes to Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium paratuberculosis
US5470723A (en) 1993-05-05 1995-11-28 Becton, Dickinson And Company Detection of mycobacteria by multiplex nucleic acid amplification
US5457027A (en) 1993-05-05 1995-10-10 Becton, Dickinson And Company Internal controls for isothermal nucleic acid amplification reactions
US5518884A (en) 1994-02-28 1996-05-21 Becton, Dickinson And Company Nucleic acid sequences specific for mycbacterium kansasii
US5639428A (en) 1994-07-19 1997-06-17 Becton Dickinson And Company Method and apparatus for fully automated nucleic acid amplification, nucleic acid assay and immunoassay
US5719020A (en) 1996-09-25 1998-02-17 Oklahoma Medical Research Foundation 4,7-dialkoxy N-acetylneuraminic acid derivatives and methods for detection of influenza type A and B viruses in clinical specimens
US5998221A (en) 1996-09-25 1999-12-07 Becton, Dickinson And Company Non-instrumented assay with quantitative and qualitative results
US6194220B1 (en) 1996-09-25 2001-02-27 Becton, Dickinson And Company Non-instrumented assay with quantitative and qualitative results
KR20000068986A (ko) 1996-11-14 2000-11-25 리차드웨드레이 신규 용도 화합물 및 그 제조방법
WO1999031280A1 (en) * 1997-12-18 1999-06-24 Sepracor Inc. Screening assays for the detection and diagnosis of influenza virus
US6394952B1 (en) 1998-02-03 2002-05-28 Adeza Biomedical Corporation Point of care diagnostic systems
US6267722B1 (en) 1998-02-03 2001-07-31 Adeza Biomedical Corporation Point of care diagnostic systems
US6303764B1 (en) 1998-09-24 2001-10-16 Zymetx, Inc. Synthesis of 4,7-dialkyl chromogenic glycosides of N-acetylneuraminic acids
WO2000063423A2 (en) 1999-04-16 2000-10-26 Zymetx, Inc. Viral detection method using viral encoded enzymes and chemiluminescent substrates
US6420552B1 (en) 1999-09-10 2002-07-16 Zymetx, Inc. Syntheses of 4-alkyl chromogenic glycosides and 7-alkyl chromogenic glycosides of N-acetylneuraminic acids
EP1253203A1 (en) 2001-04-25 2002-10-30 Becton Dickinson and Company Rapid resuscitation, growth, capture and detection of microorganisms
EP2267166B1 (en) 2003-04-25 2016-01-13 Becton Dickinson and Company Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification
US7595152B2 (en) 2005-07-01 2009-09-29 Arbor Vita Corporation Detection of influenza virus
WO2007053487A2 (en) * 2005-10-28 2007-05-10 Binax, Inc. Methods and devices for detection of the strain of a pathogen
US8163237B2 (en) 2006-05-08 2012-04-24 Becton, Dickinson And Company Vascular access device pathogenic status indication
US8007999B2 (en) * 2006-05-10 2011-08-30 Theranos, Inc. Real-time detection of influenza virus
CA2652404A1 (en) * 2006-05-18 2007-11-29 Veterinarmedizinische Universitat Wien Detection method for influenza viruses
JP2008014751A (ja) * 2006-07-05 2008-01-24 Denka Seiken Co Ltd 着色ラテックス粒子を用いるメンブレンアッセイ法およびキット
JP5300200B2 (ja) * 2006-08-31 2013-09-25 大阪府 トリインフルエンザウイルスに特異的な迅速診断法
JP5214723B2 (ja) * 2007-04-30 2013-06-19 ナノゲン・インコーポレイテッド 多分析物アッセイ
US7893272B2 (en) 2007-05-15 2011-02-22 Cellex, Inc. Reagents and kits for detection of influenza virus and the like
US8163474B2 (en) * 2008-03-15 2012-04-24 Arbor Vita Corporation NS1-NP diagnostics of influenza virus infection
WO2010139047A1 (en) * 2009-06-01 2010-12-09 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health Reagents and methods for detecting influenza virus proteins
AU2014248225B2 (en) 2013-04-01 2020-06-25 Becton, Dickinson And Company Methods and kits for the diagnosis of influenza

Also Published As

Publication number Publication date
KR102348484B1 (ko) 2022-01-07
ES2754402T3 (es) 2020-04-17
CN105264086B (zh) 2018-06-15
RU2015141509A (ru) 2017-05-16
KR20160018479A (ko) 2016-02-17
CN108663518A (zh) 2018-10-16
JP2019215377A (ja) 2019-12-19
CN108663518B (zh) 2022-03-11
JP7096219B2 (ja) 2022-07-05
AU2014248225B2 (en) 2020-06-25
EP2981618A1 (en) 2016-02-10
RU2713112C2 (ru) 2020-02-03
CA2908028C (en) 2022-10-18
US20160041167A1 (en) 2016-02-11
US12372525B2 (en) 2025-07-29
RU2015141509A3 (enExample) 2018-03-30
EP2981618B1 (en) 2019-08-28
AU2020227005B2 (en) 2022-12-08
CA2908028A1 (en) 2014-10-09
AU2014248225A1 (en) 2015-10-29
BR112015025042B1 (pt) 2023-11-14
WO2014165536A8 (en) 2016-09-01
BR112015025042A2 (enExample) 2017-09-05
WO2014165536A1 (en) 2014-10-09
CN105264086A (zh) 2016-01-20
US10317404B2 (en) 2019-06-11
JP2016524127A (ja) 2016-08-12
US11209433B2 (en) 2021-12-28
US20220146514A1 (en) 2022-05-12
US20190339272A1 (en) 2019-11-07
AU2020227005A1 (en) 2020-09-17

Similar Documents

Publication Publication Date Title
JP7096219B2 (ja) インフルエンザ診断のための方法及びキット
Nath et al. Diagnosis of herpes simplex virus: laboratory and point-of-care techniques
Bhalla et al. Opportunities and challenges for biosensors and nanoscale analytical tools for pandemics: COVID-19
Zou et al. Rapid point-of-care testing for SARS-CoV-2 virus nucleic acid detection by an isothermal and nonenzymatic Signal amplification system coupled with a lateral flow immunoassay strip
Eom et al. Diagnosis of tamiflu-resistant influenza virus in human nasal fluid and saliva using surface-enhanced Raman scattering
Kim et al. A new quantum dot-based lateral flow immunoassay for the rapid detection of influenza viruses
Liu et al. Fluorescent neuraminidase assay based on supramolecular dye capture after enzymatic cleavage
CN105917235A (zh) 用于检测感染性疾病的系统和方法
CN109580958B (zh) 一种心肌肌钙蛋白i的荧光和比色双信号检测试剂盒及检测方法
Tabata et al. Antibody-free digital influenza virus counting based on neuraminidase activity
Wang et al. Dual detection of hemagglutinin proteins of H5N1 and H1N1 influenza viruses based on FRET combined with DNase I
Link et al. Multiplexed capillary-flow driven immunoassay for respiratory illnesses
Dunbar Bead-based suspension arrays for the detection and identification of respiratory viruses
Avila-Huerta et al. Facile determination of Covid-19 seroconversion via nonradiative energy transfer
Lin et al. A biochemiluminescent assay for rapid diagnosis of influenza
McCaffrey et al. A point-of-care diagnostic platform for detecting host immune activation due to infections: cytocapture of biomarkers in situ (CyBIS)
Rashid et al. Nanobioengineering Approach for Early Detection of SARS‐CoV‐2
Chauhan et al. Recent Advances in Biosensors for Rapid Identification of Antibiotics in Dairy Products
Koskinen Two-photon excitation fluorometry in detection of infectious diseases
Lee et al. Clinical Effectiveness of Respiratory Virus Detection by FilmArray Method in Children Admitted with Respiratory Infection
Baron Multiple test methods for the detection of novel H1N1
US20100003667A1 (en) Multiple labelling for analyte detection
Sauer-Budge New Technologies for the Rapid Identification of Drug-Resistant Bacteria
Hui et al. Case Studies in Chemical and Environmental Engineering

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161014

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170330

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170330

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180126

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180312

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180608

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180912

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190225

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190513

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190725

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190819

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190918

R150 Certificate of patent or registration of utility model

Ref document number: 6591398

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250